AXIN2 and breast cancer: Moreover, their results revealed that AXIN2 rs3923086 has a protective influence in breast cancer patients older than 43 years and AXIN2 rs3923087 heterozygous AG genotype was associated with reduced risk in both the age groups (≤43 or >43) as well as in the overall study.